Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10

Authors:

Abstract
Intestinal and hepatic glucuronidation by the UDP-glucuronosyltransferases (UGTs) greatly affect the bioavailability of phenolic compounds. UGT1A10 catalyzes glucuronidation reactions in the intestine, but not in the liver. Here, our aim was to develop selective, fluorescent substrates to easily elucidate UGT1A10 function. To this end, homology models were constructed, used to design new substrates and subsequently six novel C3 substituted (4-fluorophenyl, 4-hydroxyphenyl, 4-methoxyphenyl, 4-dimethylaminophenyl, 4-methylphenyl or triazole) 7-hydroxycoumarin derivatives were synthetized from inexpensive starting materials. All tested compounds could be glucuronidated to non-fluorescent glucuronides by UGT1A10, four of them highly selectively by this enzyme. A new UGT1A10 mutant, 1A10-H210M, was prepared based on the newly constructed model. Glucuronidation kinetics of the new compounds, in both wild-type and mutant UGT1A10 enzymes, revealed variable effects of the mutation. All six new C3 substituted 7-hydroxycoumarins were glucuronidated faster by human intestine than by liver microsomes supporting the results obtained with recombinant UGTs. The most selective 4-dimethylaminophenyl and triazole C3 substituted 7-hydroxycoumarins could be very useful substrates in studying the function and expression of the human UGT1A10.
Funding Information
  • Sigrid Juséliuksen Säätiö (4704583)
  • Research Council of Finland (137589)

This publication has 44 references indexed in Scilit: